Stem cells for relevant efficient extended and normalized toxicology (SCR&Tox)
Owner/Developer: European Commission and Cosmetics Europe
| Country: | France |
|---|---|
| Languages: | English |
| Url: | http://www.scrtox.eu/ |
| Contact: | http://www.scrtox.eu/index.php?option=com_content&view=article&id=17&Itemid=6 |
| Description: |
In the development of products for use by humans it is vital to identify compounds with toxic properties at an early stage of their development, to avoid spending time and resource on unsuitable and potentially unsafe candidate products. Human pluripotent stem cell lines offer a unique opportunity to develop a wide variety of human cell-based test systems because they may be expanded indefinitely and triggered to differentiate into any cell type. SCR&Tox aims at making use of these two attributes to provide in vitro assays for predicting toxicity of pharmaceutical compounds and cosmetic ingredients. The consortium has been designed to address all issues related with biological and technological resources to meet that goal. |
| Category: | Research Program/Project/Grant |
| Channel: | Face-to-face - Website - Social media - Printed |
| Audience: | Scientists - Regulators - Industry - Researchers |
| User access: | Open access |
| Updating frequency: | Last updated: 01 November 2015 |
| Relevance: | Replacement |
| Purpose: | Regulatory testing - Toxicological and safety evaluation - Method development - Documentation and information |
| Technology/Tools: | Alternative test methods (in vitro) - Stem cells |
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.